UNICEF is uniquely positioned to support the global COVID-19 response — which extends beyond rolling out vaccines. UNICEF’s Kidus Asfaw and Dr. Abou Kampo discuss leveraging partnerships and a vast supply chain to tackle the overlooked challenges of the pandemic.
The Center for Breast Health is a multi-disciplinary center and is at the vanguard of programs offering patient-centered care, tailored to a specific disease area. Dr. Sarah McLaughlin, founding director of the center, discusses Mayo Clinic’s team-based approach to medicine.
Rita Khan, chief digital officer of Mayo Clinic, discusses the digital evolution that Mayo Clinic is embarking on as part of its 2030 strategy to cure, connect, and transform healthcare, and how the pandemic has accelerated its efforts.
Mayo Clinic has built new biotherapy facilities to support research and manufacturing of emerging immunotherapies. Dr. Qin, with appointments in cancer biology and hematology/oncology, and as director of regenerative immunotherapies, has overseen the expansion of facilities on the Florida campus.
Attorneys from Holland & Knight, one of the largest healthcare and life sciences law practices in the U.S., presented to members of the Exchange on what healthcare entrepreneurs need to know about the different FDA regulatory pathways to market for medical software.
Dr. Anjali Bhagra, medical director of the Office of Equity, Inclusion, and Diversity, clinical investigative internist, and professor of medicine at Mayo Clinic, discusses combating health disparities and research focused on enhancing resilience and stress reduction in women and healthcare professionals.
Dr. Kaveh Safavi, a senior managing director responsible for Accenture’s offerings for providers, health insurers, and public and private health systems globally, shares healthcare trends that will drive the sector’s evolution.
Dr. LaTonya J. Hickson established a broad kidney disease research agenda during her tenure as an innovator in Mayo Clinic’s top-ranked Nephrology program in Minnesota. Earlier this year Dr. Hickson relocated to the Florida campus, where she chairs the Division of Nephrology and Hypertension, leads cutting-edge research, and works with corporate innovators across the country to improve patient care.
Andrew Lackner, a leader within Accenture’s corporate innovation and new venture incubation practice, presented to members of the Exchange on fundraising practices and trends in the healthcare industry.
How can medical device startups benefit most from working with physicians? Professor Thatchenkery discusses key findings of research conducted with colleagues from Stanford and Harvard Business School, on the role of physician-users in supporting — or stymieing — a venture’s ability to innovate.